be used to assess the extent of cellular death and thereby the severity of disease and can be of help in making decisions regarding the management strategies to improve the maternal and fetal outcome. [14] [15] [16] [17] Thus, the present study was designed to estimate and compare the serum LDH levels in women with preeclampsia and normal pregnant women and to correlate LDH levels with maternal and perinatal outcome in preeclampsia.
mAteriAls And metHods
This observational prospective study was conducted on 200 antenatal women admitted labor room emergency in the Department of Obstetrics and Gynaecology in collaboration with the Department of Biochemistry at Pt. B. D. Sharma, PGIMS, Rohtak. Antenatal women with singleton pregnancy and 28 weeks onward were enrolled in the study randomly by computer-related randomization. The study was approved by the Ethical Committee of the institute. Women were divided into two groups: Group I (n = 100) comprised of pregnant women with preeclampsia (study group). Group I women were further subdivided into three categories on the basis of LDH levels: A (n = 53): <600 IU, B (n = 27): 600-800 IU, and C (n = 20): >800 IU; Group II (n = 100) comprised of normotensive pregnant women (control group). Women with chronic hypertension, medical disorders, and taking hepatotoxic drugs were excluded from the study.
After obtaining informed and written consent, the detailed history and thorough clinical examination of all participants were done. All women were subjected to routine antenatal investigations. Serum LDH levels were estimated by enzymatic method on the autoanalyzer. Participants were followed till delivery, and feral and maternal outcomes were assessed in terms of spontaneous or induced labor, gestational age at delivery, and mode of delivery. [1] LDH levels of both the groups were compared, and association of maternal and perinatal outcome was assessed in relation to LDH levels. Data thus collected were analyzed by Statistical Package for the Social Sciences version 2.4 (SPSS)/analysis. IBM SPSS Statistics: free trial version was used.
results Table 1 depicts LDH levels in the study group and distribution of patients according to LDH levels in the study group. Most of the patients (66%) in the mild preeclampsia group had LDH levels <600 IU/l. Only 30.8% of patients had LDH levels >600 IU and out of 49, patients with severe preeclampsia, 62 patients had LDH >600 IU/l. On analyzing the above data, rise in the LDH levels was observed with increasing severity of preeclampsia. Table 2 shows maternal complications according to LDH levels in the study group. Severely preeclamptic women with LDH levels >800 IU/l showed a significant increase in terms of eclampsia, abruption, hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, disseminated intravascular coagulation, and intensive care unit/respiratory ICU (ICU/RICU) transfer compared with women who had lower levels <600 IU/l. Preterm labor and intrauterine growth restriction (IUGR) had no significant increase with high LDH level. One mortality was found in women with LDH levels >800 IU/l.
There was no significant difference between subgroups of preeclampsia according to the levels of LDH in terms of Apgar at 1 min, birth asphyxia, rate of NICU admission, and stillbirth, but overall, it was observed that there was a significant difference among sepsis, mortality, and neonatal deaths (P < 0.01, <0.001, and <0.05, respectively).
discussion
On analyzing the data in the present study, it was found that there is a significant risk in the LDH levels in preeclampsia patients as compared to the control group and that there is an increase in LDH value with increasing severity of preeclampsia (P < 0.01).
Qublan et al. done demonstrated that a significant association of LDH levels with severe preeclampsia. Moreover, increase in the incidence of perinatal deaths was also observed in patients with increasing levels of serum LDH levels, with intrauterine fetal death in 4.8% cases, IUGR in 33.9%, prematurity in 77.9%, and neonatal deaths in 95.2% in the severe preeclampsia group. [18] Similar results were observed in studies conducted by Jaiswar et al., Hazari et al., and Gandhi et al. [19] [20] [21] The findings of the present study are in agreement with these studies.
Multiorgan dysfunction in severe preeclampsia caused by vascular endothelial damage leads to excessive LDH leakage and elevated levels in serum. Severely preeclamptic women with LDH levels >800 IU/l in the present study showed a significant increase in maternal complications such as eclampsia, abruption, HELLP syndrome, disseminated intravascular coagulation, and ICU/RICU transfer compared with women who had lower levels <600 IU/l. Preterm labor and IUGR showed no significant increase with high LDH levels.
Catanzarite et al. reported a subgroup of patients who had elevated levels of LDH manifested with HELLP syndrome and at a risk for developing maternal mortality. [22] Similarly, Demir et al. concluded that there was a statistically significant relation between maternal complications and high LDH levels. [23] Schwartz et al. concluded that brain edema in patients with preeclampsia-eclampsia syndrome was primarily associated with laboratory-based evidence of endothelial damage (red blood cell morphology and LDH levels). Blood pressures, although elevated in all patients, were not significantly different in those with or without brain edema. [24] An another study conducted by Jharia et al. assessed the role of serum LDH in prediction of adverse outcomes of preeclampsia. In this study, they found that poor perinatal outcome (in the form of sick/IUD) in majority of preeclampsia patients. The incidence of poor perinatal outcomes was significantly higher in preeclampsia patients with a higher level of serum LDH (>600 IU/L). [25] In the present study, it was illustrated that there was a significant difference among sepsis, mortality, and neonatal deaths (P < 0.01, <0.001, and <0.05, respectively) in the subgroups of preeclampsia according to the levels of LDH. However, in terms of Apgar at 1 min, birth asphyxia, rate of NICU admission, and stillbirth, no significant difference was observed.
He et al. found that preeclamptic women with small-for-gestational-age infants had significantly higher LDH concentrations than those in the appropriate-for-gestational-age group, but alanine transaminase and aspartate aminotransferase concentrations did not increase significantly. [26] Munagavalasa et al. conducted a case-control study to know the levels of serum LDH in preeclampsia patients and the association between LDH levels and fetal outcome and found higher serum LDH levels in preeclampsia patients as compared to controls. The fetal outcome was poor in the group having high LDH levels, and they concluded that serum levels of LDH can be used as a biochemical predictor for the prognosis of preeclampsia. [27] LDH levels were found significantly increased in patients of preeclampsia as compared to normotensive women. It was observed that maternal complications such as eclampsia, disseminated impending coagulopathy, abruption, and HELLP syndrome and perinatal complications such as low birth weight and preterm delivery were associated with higher LDH levels in preeclampsia patients. Since LDH levels are associated with severity of preeclampsia and occurrence of complications of preeclampsia, these women with higher LDH levels require vigilant monitoring and prompt management to prevent/ decrease the maternal and perinatal complications. conclusion LDH levels are associated with severity of preeclampsia and occurrence of maternal and fetal complications. vigilant monitoring of these women might be of help in decreasing maternal and perinatal complications.
